Anti-inflammatory components of the Vietnamese starfish 
             by unknown
Thao et al. Biological Research  (2015) 48:12 
DOI 10.1186/s40659-015-0002-2RESEARCH ARTICLE Open AccessAnti-inflammatory components of the Vietnamese
starfish Protoreaster nodosus
Nguyen Phuong Thao1,2, Bui Thi Thuy Luyen1,2, Jung Eun Koo3, Sohyun Kim3, Young Sang Koh3,
Nguyen Xuan Cuong1, Nguyen Hoai Nam1, Phan Van Kiem1, Young Ho Kim2* and Chau Van Minh1*Abstract
Background: In the present study, we examined the inhibitory effects of a methanolic extract, dichloromethane
fraction, water layer, and polyhydroxylated sterols (1–4) isolated from the Vietnamese starfish Protoreaster nodosus
on pro-inflammatory cytokine (IL-12 p40, IL-6, and TNF-α) production in LPS-stimulated bone marrow-derived
dendritic cells (BMDCs) using enzyme-linked immunosorbent assays (ELISA).
Results: The methanolic extract and dichloromethane fraction exerted potent inhibitory effects on the production
of all three pro-inflammatory cytokines, with IC50 values ranging from 0.60 ± 0.01 to 26.19 ± 0.64 μg/mL. Four highly
pure steroid derivatives (1–4) were isolated from the dichloromethane fraction and water layer of P. nodosus. Potent
inhibitory activities were also observed for (25S) 5α-cholestane-3β,4β,6α,7α,8β,15α,16β,26-octol (3) on the production of
IL-12 p40 and IL-6 (IC50s = 3.11 ± 0.08 and 1.35 ± 0.03 μM), and for (25S) 5α-cholestane-3β,6α,8β,15α,16β,26-hexol
(1) and (25S) 5α-cholestane-3β,6α,7α,8β,15α,16β,26-heptol (2) on the production of IL-12 p40 (IC50s = 0.01 ± 0.00
and 1.02 ± 0.01 μM). Moreover, nodososide (4) exhibited moderate inhibitory effects on IL-12 p40 and IL-6 production.
Conclusion: This is the first report of the anti-inflammatory activity from the starfish P. nodosus. The main finding of this
study is the identification oxygenated steroid derivatives from P. nodosus with potent anti-inflammatory activities that
may be developed as therapeutic agents for inflammatory diseases.
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Inflammation is one of the earliest innate immune re-
sponses to tissue injury and various pathological stimuli.
It is also a critical early factor in wound healing. Delayed
or impaired inflammation may affect the later stages of
wound healing, especially granulation formation [1,2].
Inflammation, which represents part of the complex bio-
logical response of vascular tissue to harmful exogenous
harmful stimuli, is mediated by a variety of soluble fac-
tors, including a group of secreted polypeptides known
as cytokines, which play key roles in the modulation of
immune responses [3].
Interleukin (IL)-12 is a pro-inflammatory cytokine pro-
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bacterial products and immune signals [4]. Originally
identified as a B-cell differentiation factor, IL-6 is now
known to be a multifunctional cytokine that participates
in several biological events, including immune responses,
hematopoiesis, and acute-phase reactions [5]. The regula-
tory effects of IL-6 involve the inhibition of tumor necrosis
factor (TNF) production, providing negative feedback, and
limiting acute inflammatory responses [6,7]. Cytokines
such as IL-6 are essential, but their constitutive overpro-
duction is involved in various diseases. This account for
the negative regulatory mechanism in the IL-6 signaling
system [8,9].
TNF has since been implicated in diverse inflammatory,
infectious, and malignant conditions, and the importance
of TNF in inflammation was demonstrated by the efficacy
of anti-TNF antibodies or the administration of soluble
TNF receptors (TNFRs) in controlling rheumatoid arth-
ritis and other inflammatory conditions [10,11]. TNF is
not typically detectable in healthy individuals, but serumhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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infection [12]. Additionally, serum TNF levels correlate
with the severity of infections [11]. Therefore, inhibiting
the expression and production of powerful mediators,
including IL-12 p40, IL-6, and TNF-α, using anti-
inflammatory components could represent a prevent-
ive or therapeutic target, and may be used to develop
anti-inflammatory agents for health promotion and
disease prevention.
Starfish are found in all oceans. There are more than
1,500 known species, and many remain undiscovered.
Forcipulatida, Paxillosida, Platyasterida, Spinulosida, and
Valvatida are the main subclasses of Asteroidea. Starfish
have been investigated by organic chemists, biochemists,
and pharmacologists as a potential source of bioactive
marine natural products. Various secondary metabolites,
including steroids, steroidal glycosides, anthraquinones,
alkaloids, phospholipids, peptides, and fatty acids, have
been reported in starfish [13]. Steroids and their glyco-
sylated derivatives with unique structures are known to
possess anti-tumor, anti-inflammatory [14], immuno-
modulatory, anti-allergy, anti-fungal, hemolytic [15], neur-
itogenic [16], antinociceptive [17], cytotoxic [18-20], and
anti-viral [21] activities.Figure 1 The chemical structures of oxygenated derivatives of cholesThe starfish Protoreaster nodosus (Linnaeus, 1758) is
an invertebrate belong to the order Phanerozonia, class
Asteroidea, and phylum Echinodermata. Members of the
genus Protoreaster are found in the warm Vietnamese
sea, and have been historically used as tonic agents in
Vietnamese folk medicine. However, studies on the bio-
logical activities of P. nodosus are limited. In previous
studies, the main constituents of P. nodosus were found
to be polyhydroxylated steroids [22], several of which ex-
hibited moderate cytotoxicity, steroidal glycoside sulfates
[23], galactocerebrosides [24], and gangliosides [25].
As part of our ongoing investigations of Vietnamese
marine organisms regarding anti-inflammatory activity
[26-31], we found that a methanolic extract and dichloro-
methane fraction of P. nodosus showed significant in vitro
anti-inflammatory effects. The present study details the
inhibitory effect of steroid derivatives (1–4, Figure 1) from
the starfish P. nodosus on the LPS-induced expression of
the pro-inflammatory cytokines IL-12 p40, IL-6, and
TNF-α in BMDCs.
Results and discussion
Natural marine products have recently become the focus
of increased research interest due to their potentialterol (1–4) from P. nodosus.
Table 1 Anti-inflammatory effects of the extract/fractions
on LPS-stimulated BMDCs
Extract/fractions IC50 values (μg/mL)
a
IL-12 p40 IL-6 TNF-α
CH2Cl2 fraction 0.60 ± 0.01 3.29 ± 0.09 10.29 ± 0.34
Water layer 4.03 ± 0.10 80.76 ± 1.96 >100
MeOH extract 2.48 ± 0.08 8.57 ± 0.21 26.19 ± 0.64
SB203580b 2.52 ± 0.12 1.67 ± 0.13 3.65 ± 0.12
aThe inhibitory effects are represented as giving 50% inhibition (IC50) relative
to the vehicle control. These data represent the average values of three repeated
experiments (mean ± SD). IC50 values for selected extracts are given in column
IL-12 p40, IL-6 and TNF-α. Values <100 μg/mL are considered to be active.
bSB203580 was used as a positive control.
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Oxysterols, or oxygenated derivatives of cholesterol pro-
duced through autooxidation or in vivo enzymatic pro-
cesses, and have been identified in mammalian tissues and
cells (e.g., blood) and processed foods. Oxysterols are
emerged as intriguing substances with diverse biological
activities [34,35]. Recently, it was shown that oxysterol-
induced cell death shares many common features with
apoptotic cell death [19], which plays an important role
in the balance between cell proliferation and cell death.
A wide range of stimuli can trigger cell death, which is
an irreversible process [20,36].
BMDCs play a key role in the interface between the
innate and acquired immune systems. Activated BMDCs
perform crucial functions in immune and inflammatory
responses via the pathogen-associated molecular patterns
(PAMPs)-stimulated production of pro-inflammatory
cytokines such as IL-12 p40, IL-6, and TNF-α, which
are involved in the pathogenesis of cardiovascular and
neurodegenerational diseases and cancers through a
series of cytokine signaling pathways. It has been dem-
onstrated that pro-inflammation is associated with
pathophysiology and is connected with various clinical
disease manifestations. These pro-inflammatory cyto-
kines play a crucial role in host defenses and inflamma-
tion [37,38].
Among its many biological activities, IL-12 provides
an obligatory signal for the differentiation of effector
T-helper type 1 (Th1) cells and the secretion of Th1
cytokines, gamma interferon (IFN-γ), and IL-2. IL-12
plays an important role in the generation of Th1 responses
to human pathogens [23,24]. Although the induction of
IL-12 by intracellular organisms is necessary for a protect-
ive host Th1 response, the overexpression of Th1 cyto-
kines and IL-12 may contribute to the development and
perpetuation of chronic inflammatory and autoimmune
diseases. Thus, understanding the regulated expression
of IL-12 in macrophages may provide insight into the
pathogenesis of infectious and inflammatory diseases,
and could reveal novel approaches to altering immune
responses [39].
To date, the anti-inflammatory effects of extracts and/or
compounds isolated from the starfish P. nodosus have not
been reported. Therefore, we assayed the anti-inflammatory
activity of a methanolic extract, dichloromethane-soluble
fraction, and water layer on pro-inflammatory cytokine
(IL-12 p40, IL-6, and TNF-α) production in LPS-
stimulated BMDCs using ELISA (Table 1). BMDCs were
incubated in 48-well plates and treated for 1 h with the
isolated compounds prior to stimulation with LPS
(10.0 ng/mL). Supernatants were harvested 18 h after
stimulation. Upon LPS treatment, dendritic cells (DCs)
are known to secrete pro-inflammatory cytokines, in-
cluding IL-12p40, IL-6, and TNF-α.The methanolic extract significantly inhibited pro-
inflammatory cytokine production, while the dichloro-
methane fraction and water layer showed more potent
inhibitory effects (Figure 2). The methanolic extract of
P. nodosus had inhibitory effects on IL-12 p40, IL-6, and
TNF-α production (IC50S = 2.48 ± 0.08, 8.57 ± 0.21, and
26.19 ± 0.64 μg/mL, respectively). Since the methanolic
extract significantly reduced inflammation, it was partitioned
in dichloromethane/water to obtain a dichloromethane-
soluble portion and an aqueous phase. As shown in
Table 1, the dichloromethane-soluble fraction showed
potent inhibitory activity towards LPS-stimulated IL-12
p40 and IL-6 production (IC50s = 0.60 ± 0.01 and 3.29 ±
0.09 μg/mL, respectively), which was greater than in the
presence of the methanolic extract (IC50s = 2.48 ± 0.08
and 8.57 ± 0.21 μg/mL). Moreover, the aqueous layer
exerted potent suppressive effects on the production of
IL-12 p40 (IC50 = 4.03 ± 0.10 μg/mL).
Subsequently, all of the isolated steroid derivatives (1–4)
from the dichloromethane fraction and water layer of P.
nodosus were tested for inhibitory effects on the produc-
tion of the pro-inflammatory cytokines IL-12 p40, IL-6,
and TNF-α. The results obtained with 3-(4,5-dimethyl-2,5
thiazolyl)-2,5 diphenyl tetrazolium bromide (MTT) assays
showed that steroid derivatives (1–4) did not exhibit sig-
nificant cytotoxicity at concentrations up to 50.0 μM at
24 h (data not shown). Of the tested compounds, 1–3
exerted greater inhibitory effects than SB203580 on IL-12
p40 production with IC50 values of 0.01 ± 0.00, 1.02 ± 0.01,
and 3.11 ± 0.08 μM, respectively, at the various concentra-
tion (Figure 3 and Table 2). This variability in inflamma-
tory response inhibition by 1–3 may be explained by the
secretion of different levels of inflammatory factors upon
LPS-stimulation.
Comparing the observed effects between the structurally
steroid derivatives, (25S) 5α-cholestane-3β,6α,8β,15α,16β,
26-hexol (1) is similar to that of (25S) 5α-cholestane-
3β,6α,7α,8β,15α,16β,26-heptol (2) and (25S) 5α-cholestane-
3β,4β,6α,7α,8β,15α,16β,26-octol (3), except for the presence
of hydroxy groups located at C-4 and/or C-7 in compounds
Figure 2 The effect of extract/fractions (1.0, 2.0, 5.0, and 10.0 μg/mL) on IL-12 p40 (A), IL-6 (B), and TNF-α (C) production by LPS-stimulated
BMDCs. The data were presented as inhibition rate (%) compared to the value of vehicle-treated DCs. SB203580 was used as a positive control (Pos.).
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activity towards LPS-stimulated IL-12 p40 production
(IC50 = 0.01 ± 0.00 μM), which was comparable to thatof the positive control, SB203580 (IC50 = 5.00 ± 0.16 μM).
Previously, compounds 1–3 were isolated from Aster-
ina pectinifera, Pentaceraster alveolatus, and Oreaster
Figure 3 The effect of oxygenated derivatives of cholesterol 1–4 (0.1 to 50.0 μM) on IL-12 p40 production by LPS-stimulated BMDCs.
The data were presented as inhibition rate (%) compared to the value of vehicle-treated DCs. SB203580 was used as a positive control.
Comp.: compound.
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antiviral activity against herpes simplex virus type 1
(HSV-1) and their cytotoxicity against human liver car-
cinoma (HepG2) cells in vitro [40]. Nodososide (4) is a
polyhydroxylated steroid glycoside. Structurally, these
glycosides are oxygenated derivatives of cholesterol
that are glycosylated with a disaccharide chain, but 4
exhibited a moderate effect (IC50 = 12.47 ± 0.38 μM) up
to 50.0 μM, relative to the vehicle group. Our finding
that steroid derivatives (1–3) possess significant anti-
inflammatory activity suggests that these related ste-
roids might be interesting for further investigations for
potential inflammatory diseases.
IL-6 is a pro-inflammatory cytokine that induces in-
flammatory upon secretion by T cells and macrophages
in response to trauma, especially burns or other types of
tissue damage [43]. It also strongly activates the immune
system and enhances inflammatory responses, although
based on some of its effects, it may also be classified as
anti-inflammatory cytokine. Regarding IL-6, the methano-
lic extract and dichloromethane-soluble fraction showed
inhibitory ciliary neurotropic factor activity toward LPS-Table 2 Anti-inflammatory effects of compounds (1–4) on LPS
Compounds IC
IL
(25S) 5α-Cholestane-3β,6α,8β,15α,16β,26-hexol (1) 0
(25S) 5α-Cholestane-3β,6α,7α,8β,15α,16β,26-heptol (2) 1
(25S) 5α-Cholestane-3β,4β,6α,7α,8β,15α,16β,26-octol (3) 3
Nodososide (4) 1
SB203580b 5
aThe inhibitory effects are represented as giving 50% inhibition (IC50) relative to the
experiments (mean ± SD). IC50 values for selected extracts are given in column IL-12
bSB203580 was used as a positive control.stimulated IL-6 production (IC50s = 8.57 ± 0.21 and 3.29 ±
0.09 μg/mL, respectively). (25S) 5α-cholestane-3β,4β,6α,
7α,8β,15α,16β,26-octol (3) inhibited IL-6 production sig-
nificantly in LPS-stimulated BMDCs, with an IC50 value
of 1.35 ± 0.03 μM (Table 2). The inhibitory effects of
nodososide (4) included moderate inhibition of IL-6 pro-
duction, with an IC50 value of 23.18 ± 0.46 μM (Figure 4).
The remaining compounds did not show significant activ-
ity (IC50 > 100 μM) against IL-6 production.
Overexpression of the pro-inflammatory cytokines
TNF-α and IL-6 is associated with the development of
autoimmune, inflammatory, and immunopathological
diseases. Therefore, blocking TNF-α, IL-6, and their re-
spective signaling pathways may be effective for the treat-
ment of inflammatory diseases. According to our results,
the methanolic extract and dichloromethane-soluble frac-
tion showed inhibitory effects on LPS-stimulated TNF-α
production (IC50s = 26.19 ± 0.64 and 10.29 ± 0.34 μg/mL,
respectively). Notably, not all of the isolated steroid deriv-
atives (1–4) had significant inhibitory effects on TNF-α
production (IC50 > 100 μM, Table 1 and 2). However, it is
interesting to note that the methanolic extract extract and-stimulated BMDCs
50 values (μM)
a
-12 p40 IL-6 TNF-α
.01 ± 0.00 >100 >100
.02 ± 0.01 >100 >100
.11 ± 0.08 1.35 ± 0.03 >100
2.47 ± 0.38 23.18 ± 0.46 >100
.00 ± 0.16 3.50 ± 0.12 7.20 ± 0.13
vehicle control. These data represent the average values of three repeated
p40, IL-6 and TNF-α. Values <100 μM are considered to be active.
Figure 4 The effect of oxygenated derivatives of cholesterol 3 and 4 (1.0 to 50.0 μM) on IL-6 production by LPS-stimulated BMDCs.
The data were presented as inhibition rate (%) compared to the value of vehicle-treated DCs. SB203580 was used as a positive control.
Comp.: compound.
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active than the isolated steroid derivatives (1–4), suggest-
ing the presence of other active derivatives, which could
act individually or by synergy with the isolated steroid de-
rivatives (1–4).
Conclusion
In conclusion, the methanolic extract and dichlorometh-
ane fraction showed potent inhibitory effects on the pro-
duction of all three pro-inflammatory cytokines, with
IC50 values ranging from 0.60 ± 0.01 to 26.19 ± 0.64 μg/mL.
Potent inhibitory activities were observed for (25S) 5α-
cholestane-3β,4β,6α,7α,8β,15α,16β,26-octol (3) on the
production of IL-12 p40 and IL-6, and for (25S) 5α-
cholestane-3β,6α,8β,15α,16β,26-hexol (1) and (25S) 5α-
cholestane-3β,6α,7α,8β,15α,16β,26-heptol (2) on the
production of IL-12 p40. Moreover, nodososide (4)
exerted moderate inhibitory effects on IL-12 p40 and
IL-6 production. Additional studies are required to as-
sess the mechanisms of action of these compounds and
their potential use as novel anti-inflammatory agents.
These results support the use of starfish steroid com-
ponents to inhibit the secretion of pro-inflammatory
cytokines, including IL-12 p40, IL-6, and TNF-α, and
to prevent and treat inflammatory diseases.
Methods
General experimental procedures
Optical rotations were determined on a JASCO P-2000
polarimeter. The UV spectrum was recorded on a
JASCO V-630 spectrophotometer. IR spectra were ob-
tained on a Bruker TENSOR 37 FT-IR spectrometer.
The 1H NMR (500 MHz) and 13C NMR (125 MHz)
spectra were recorded on a Bruker AM500 FT-NMR
spectrometer and TMS was used as an internal standard.
Column chromatography (CC) was performed on silicagel (Kieselgel 60, 70–230 mesh and 230–400 mesh,
Merck), porous polymer gel (Mitsubishi Chemical, Diaion
HP-20, 70 × 180 mm), octadecyl silica (ODS, Cosmosil
140 C18-OPN, Nacalai Tesque), and YMC RP-18 resins
(30–50 μm, Fuji Silysia Chemical). Thin layer chromatog-
raphy (TLC) used pre-coated silica gel 60 F254 (1.05554.0001,
Merck) and RP-18 F254S plates (1.15685.0001, Merck) and
compounds were visualized by spraying with aqueous 10%
H2SO4 and heating for 3–5 minutes.
Marine material
The sample of the starfish P. nodosus was collected at
Ha Long, Quangninh, Vietnam, in October 2012 and
identified by Prof. Do Cong Thung (Institute of Marine
Resources and Environment, VAST, Hanoi, Vietnam). A
voucher specimen (PN-VHS-2012) was deposited at the
Institute of Marine Resources and Environment and
Institute of Marine Biochemistry, VAST, Vietnam.
Extraction and isolation
Fresh frozen samples of the starfish P. nodosus (5.0 kg)
were ground and extracted three times with hot MeOH
(at 50°C for 3 h each time). The obtained solutions were
filtered, combined, and concentrated under reduced
pressure to yield a dark viscous residue (56.0 g, A).
This residue was suspended in water (1.0 L) and parti-
tioned in turn with CH2Cl2 (3 × 1.0 L). The combined
dichloromethane-soluble portions were evaporated under
reduced pressure to afford CH2Cl2 fraction (27.5 g, B) and
water layer (C).
Extract B was crudely separated by silica gel (CC)
using gradient concentrations of ethyl acetate (EtOAc)
in n-hexane from 0 to 100% to yield four fractions (B-1
to B-4). Fraction B-4 (2.31 g) was further separated by sil-
ica gel CC using CH2Cl2-MeOH-H2O (5:1:0.1) as eluents,
to give three subfractions (B-1.1 to B-1.4). Subfraction
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eluent of CH2Cl2-MeOH (3.5:1), and further purified
by reversed-phase flash CC (YMC Gel ODS-A, 60 Å,
400/500 mesh) and eluting with MeOH-H2O (2:1) to
afford (25S) 5α-cholestane-3β,6α,8β,15α,16β,26-hexol
(1, 2.1 mg). Next, (25S) 5α-Cholestane-3β,6α,7α,8β,
15α,16β,26-heptol (2, 1.8 mg) was purified via the sub-
fraction of B-1.2 (0.21 g) by silica gel CC and eluting
with CH2Cl2-MeOH (4.5:1). Similarly, subfraction B-1.1
(4.16 g) was subjected to YMC RP-18 CC, using MeOH-
acetone-H2O (80:10:10) to yield (25S) 5α-cholestane-
3β,4β,6α,7α,8β,15α,16β,26-octol (3, 2.3 mg).
The water layer was desalted by Diaion™ HP-20 CC
and eluted first with water and then with MeOH. The
desalted water residue (6.2 g, C) was separated by silica
gel CC and eluted with CH2Cl2-MeOH (from 25:10:1, v/v/v)
to yield five fractions (C-1 to C-5). Fraction C-3 (1.2 g)
was separated by silica gel CC, using CH2Cl2-MeOH (5:1)
as the eluent to yield three subfractions (C-3.1 to C-3.3).
Finally, subfraction C-3.3 (0.15 g) was further separated by
Sephadex® LH-20 CC using acetone-MeOH (1:2) as the
mobile phase, followed by YMC RP-18 CC using MeOH-
H2O (1:1) to afford nodososide (4, 3.5 mg).
Marine product derivatives
In total, 5.0 kg of finely chopped material were extracted
with MeOH (5.0 L) in glass jars with screw-on lids. The
methanolic extracts were filtered, combined, and con-
centrated using a rotary vacuum evaporator at 40°C and
then further dried in vacuo at ambient temperature for
24 h. From the dichloromethane fraction and water layer
of P. nodosus, four highly pure steroid derivatives (1–4)
were isolated and their structures elucidated. Stock solu-
tions of the tested compounds were prepared in di-
methyl sulfoxide (DMSO), kept at −20°C, and diluted to
the desired final concentration in fresh medium before
each experiment. The final concentration of DMSO did
not exceed 0.5% in any of the experiments to avoid ef-
fects cell growth.
Cell viability assay
The cell viability was determined by standard procedure
of MTT assays (Sigma, St. Louis, MO, USA), which was
based on the reduction of the dye MTT to formazan
crystals, an insoluble intracellular blue product, by cellu-
lar dehydrogenases. Briefly, the cells at a concentration
of 5 × 104 cells were seeded on a 96-well culture plate.
After incubation for 1 h at 37°C, cells were treated with
extract, fractions, and compounds at various concentra-
tions for 24 h. Cells were added 0.2 mg MTT (Sigma, St.
Louis, MO) and then incubated at 37°C for 4 h. The plate
was centrifuged and the supernatants were aspirated. The
formazan crystals in each well were dissolved in 250 μL
DMSO (Amresco, OH). The plates were agitated to ensurecomplete dissolution of the purple formazan crystals, and
the optical density was measured at the wavelength
540 nm using an ELISA reader (Packard, Instrument Co.,
Downers Grove, IL).Cell cultures
In this study, we used LPS-stimulated BMDCs as a model
for testing the inhibitory effects of fractions and isolated
compounds on the secretion of pro-inflammatory cyto-
kines IL-12 p40, IL-6, and TNF-α. BMDCs (1 × 105) were
seeded in 48-well plates at 37°C, 5% CO2 for 1 h, and then
treated for 1 h with the compounds at concentrations of
0.1 to 50.0 μM, followed by stimulation with LPS
(10.0 ng/mL, Figure 3). The supernatants were harvested
18 h after stimulation and IL-12 p40 secretion was mea-
sured using ELISA. SB203580, an inhibitor of cytokine
suppressive binding protein/p38 kinase, was used as a
positive control [44]. SB203580 inhibited IL-12 p40, IL-6,
and TNF-α production with IC50 values of 5.00 ± 0.16,
3.50 ± 0.12, and 7.20 ± 0.13 μM, respectively.
Bone marrow-derived dendritic cells were grown from
wild-type C57BL/6 mice (Orient Bio Inc., Seoul, Korea)
as previously described [45]. All animal procedures were
approved by and performed according to the guidelines
of the Institutional Animal Care and Use Committee of
Jeju National University (#2010-0028). Briefly, the mouse
tibia and femur was obtained by flushing with Dulbecco’s
modified Eagle medium to yield bone marrow cells. The
cells were cultured in Rosell Park Memorial Institute
(RPMI) 1640 medium containing 10% heat-inactivated
fetal bovine serum (FBS; Gibco, Grand Island, NY, USA),
50.0 μM β-mercaptoethanol, and 2.0 mM glutamine
supplemented with 3% J558L hybridoma cell culture
supernatant containing granulocyte-macrophage colony-
stimulating factor (GM-CSF). The culture medium was
replaced with fresh medium every other day. At day six of
culture, non-adherent cells and loosely adherent dendritic
cell (DC) aggregates were harvested, washed, and resus-
pended in RPMI 1640 supplemented with 5% FBS.Cytokine production measurements
The BMDCs were incubated in 48-well plates in 0.5 mL
containing 1 × 105 cells per well, and then treated with
the isolated compounds (1–4) at different concentra-
tions for 1 h before stimulation with 10.0 ng/mL LPS
from Salmonella minnesota (Alexis, Famingdale, NY,
USA). Supernatants were harvested 18 h after stimula-
tion. Concentrations of murine IL-12 p40, IL-6, and
TNF-α, in the culture supernatant were determined by
ELISA (BD PharMingen, San Diego, CA, USA) accord-
ing to the manufacturer’s instructions. The data are pre-
sented as means ± S.D. of at least three independent
experiments performed in triplicate.
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IL-12 p40 level in LPS-stimulated DC: 51.34 ± 0.66
(ng/mL). IL-6 level in unstimulated DC: not detectable.
IL-6 level in LPS-stimulated DC: 41.12 ± 2.38 (ng/mL).
TNF-α level in unstimulated DC: not detectable. TNF-α
level in LPS-stimulated DC: 1.83 ± 0.02 (ng/mL).
The inhibitory activity (I) was expressed as the inhib-





Cdcv: Cytokine level (ng/mL) in vehicle treated DC;
Cdcc: Cytokine level (ng/mL) in compound treated DC.
Statistical analysis
The results are expressed as mean value ± S.D. Statistical
analysis was performed using one-way ANOVA. P < 0.05
was considered statistically significant.
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